As in recent meta-analyses [19, 20], including at most half of the studies in our present analysis, we now showed relatively strong positive associations with ER and/or PR positive subtypes (ER+, PR+, ER+ PR+) of postmenopausal BC, and no statistically significant associations with receptor-negative subtypes. The gene discussed is PGR; the disease is breast cancer.